CirculoGene Diagnostics circulogene.com


Public lists: Genomics (493)

Circulogene is a personalized medicine company that is developing what the company calls a "liquid biopsy" that is based on the discovery that as tumors grow, they also die, releasing their DNA into the bloodstream. Circulogene's liquid biopsy tumor DNA sequencing is a test that aims to combine finger-stick volumes of blood and next-generation sequencing (NGS) to monitor tumor-mutant DNA within well-characterized, well-documented, cancer-associated genes.

Circulogene is a personalized medicine company that is developing what the company calls a "liquid biopsy" that is based on the discovery that as tumors grow, they also die, releasing their DNA into the bloodstream. Circulogene's liquid biopsy tumor ...Show all

Company (Alive / Active)

Phone: 855-614-7083

Fax:

3125 Independence Drive
Suite 301
Birmingham, 35209
Alabama, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
CirculoGene Diagnostics $3.7M Jan 25, 2018
See all 3 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related CirculoGene Diagnostics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

MTM Laboratories

Westborough, Massachusetts, United States
Acquiredmtm laboratories AG is an in-vitro diagnostic company that develops, manufactures, and markets products for the early detection and diagnosis of cervical and other cancers.Login to see details

Genomic Health

Redwood City, California, United States
IPO / Went publicGenomic Health is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched its first test, Oncotype DX(TM), which has been shown to predict the likelihood of breast cancer recurrence and chemotherapy benefit in early stage breast cancer patients.Login to see details
See all 3 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)